For: | Mitsuyama K, Niwa M, Takedatsu H, Yamasaki H, Kuwaki K, Yoshioka S, Yamauchi R, Fukunaga S, Torimura T. Antibody markers in the diagnosis of inflammatory bowel disease. World J Gastroenterol 2016; 22(3): 1304-1310 [PMID: 26811667 DOI: 10.3748/wjg.v22.i3.1304] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i3/1304.htm |
Number | Citing Articles |
1 |
Oren Koslowe, Joel R. Rosh. Inflammatory Bowel Disease. Clinical Gastroenterology 2017; : 257 doi: 10.1007/978-3-319-53763-4_15
|
2 |
Arie Levine, Neil Chanchlani, Seamus Hussey, Tomer Ziv-Baran, Johanna C Escher, Jorge Amil Dias, Gabor Veres, Sibylle Koletzko, Dan Turner, Kaija-Leena Kolho, Anders Paerregaard, Annamaria Staiano, Paolo Lionetti, Federica Nuti, Malgorata Sladek, Ron Shaoul, Isabella Lazowska-Prezeorek, Javier Martin de Carpi, Rotem Sigall Boneh, Tamar Pfeffer Gik, Noa Cohen-Dolev, Richard K Russell. Complicated Disease and Response to Initial Therapy Predicts Early Surgery in Paediatric Crohn’s Disease: Results From the Porto Group GROWTH Study. Journal of Crohn's and Colitis 2020; 14(1): 71 doi: 10.1093/ecco-jcc/jjz111
|
3 |
Laila Aldars-García, María Chaparro, Javier P. Gisbert. Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease. Microorganisms 2021; 9(5): 977 doi: 10.3390/microorganisms9050977
|
4 |
Emiko Mizoguchi, Renuka Subramaniam, Toshiyuki Okada, Atsushi Mizoguchi. A Review of Selected IBD Biomarkers: From Animal Models to Bedside. Diagnostics 2021; 11(2): 207 doi: 10.3390/diagnostics11020207
|
5 |
Michael Shpoliansky, Dirk Roggenbuck, Marina Pinsker, Naomi Salamon, Batia Weiss, Dror S. Shouval, Lael Werner. Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn’s Disease. Digestive Diseases and Sciences 2021; 66(8): 2619 doi: 10.1007/s10620-020-06589-5
|
6 |
Michelle Khrom, Millie Long, Shishir Dube, Lori Robbins, Gregory J. Botwin, Shaohong Yang, Emebet Mengesha, Dalin Li, Takeo Naito, Nirupama N. Bonthala, Christina Ha, Gil Melmed, Shervin Rabizadeh, Gaurav Syal, Eric Vasiliauskas, David Ziring, Steven R. Brant, Judy Cho, Richard H. Duerr, John Rioux, Phil Schumm, Mark Silverberg, Ashwin N. Ananthakrishnan, William A. Faubion, Bana Jabri, Sergio A. Lira, Rodney D. Newberry, Robert S. Sandler, Ramnik J. Xavier, Subra Kugathasan, David Hercules, Stephan R. Targan, R. Balfour Sartor, Talin Haritunians, Dermot P.B. McGovern. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease. Gastroenterology 2024; 167(2): 315 doi: 10.1053/j.gastro.2024.02.026
|
7 |
Daniela L. Jabes, Yara N. L. F. de Maria, David Aciole Barbosa, Kaltinaitis B. N. H. Santos, Lucas M. Carvalho, Ana Carolina Humberto, Valquíria C. Alencar, Regina Costa de Oliveira, Miguel L. Batista, Fabiano B. Menegidio, Luiz R. Nunes. Fungal Dysbiosis Correlates with the Development of Tumor-Induced Cachexia in Mice. Journal of Fungi 2020; 6(4): 364 doi: 10.3390/jof6040364
|
8 |
Andreas Munk Petersen. Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases. APMIS 2022; 130(S144): 1 doi: 10.1111/apm.13256
|
9 |
Sayan Malakar. Clinical Significance of C-reactive Protein. 2020; : 59 doi: 10.1007/978-981-15-6787-2_3
|
10 |
Keisuke Hata, Soichiro Ishihara, Hiroaki Nozawa, Kazushige Kawai, Tomomichi Kiyomatsu, Toshiaki Tanaka, Junko Kishikawa, Hiroyuki Anzai, Toshiaki Watanabe. Pouchitis after ileal pouch‐anal anastomosis in ulcerative colitis: Diagnosis, management, risk factors, and incidence. Digestive Endoscopy 2017; 29(1): 26 doi: 10.1111/den.12744
|
11 |
Shinsaku Hamanaka, Tomoo Nakagawa, Takaki Hiwasa, Yuki Ohta, Shingo Kasamatsu, Hideaki Ishigami, Takashi Taida, Kenichiro Okimoto, Keiko Saito, Daisuke Maruoka, Tomoaki Matsumura, Hirotaka Takizawa, Koichi Kashiwado, Sohei Kobayashi, Kazuyuki Matsushita, Hisahiro Matsubara, Tatsuro Katsuno, Makoto Arai, Naoya Kato. Investigation of novel biomarkers for predicting the clinical course in patients with ulcerative colitis. Journal of Gastroenterology and Hepatology 2018; 33(12): 1975 doi: 10.1111/jgh.14297
|
12 |
Camila Sanchez Cruz, Anahi Rojas Huerta, Jesus Lima Barrientos, Cristina Rodriguez, Aarfa Devani, Vanessa Boosahda, Naga S Rasagna Mareddy, Gabriela Briceno Silva, Jose C Del Castillo Miranda, Kevin A Reyes Gochi, Mario D Reyes Gochi , Samantha Alvarez, Patricia E Ghattas Hasbun. Inflammatory Bowel Disease and Cardiovascular Disease: An Integrative Review With a Focus on the Gut Microbiome. Cureus 2024; doi: 10.7759/cureus.65136
|
13 |
Ki-Uk Kim, Jisu Kim, Wan-Hoon Kim, Hyeyoung Min, Chang Hwan Choi. Treatments of inflammatory bowel disease toward personalized medicine. Archives of Pharmacal Research 2021; 44(3): 293 doi: 10.1007/s12272-021-01318-6
|
14 |
Mária Kolesárová, Anita Vassová, Dana Marcinčáková, Ján Kyselovič, Andrea Gažová. Analysis of Crohn´s disease pharmacotherapy in the child and adult population. Klinická farmakologie a farmacie 2023; 37(2): 52 doi: 10.36290/far.2023.009
|
15 |
Laura Räisänen, Nitin Agrawal, Binu Mathew, Sohvi Kääriäinen, Kaija-Leena Kolho, Heli Viljakainen. Pre-Diagnostic Saliva Microbiota of School-Aged Children Who Developed Type 1 Diabetes or Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2023; 24(9): 8279 doi: 10.3390/ijms24098279
|
16 |
Chiao-Chi Ou, Yen-Ching Wu, Jun-Peng Chen, Wen-Nan Huang, Yi-Hsing Chen, Yi-Ming Chen. Association of atypical anti-neutrophil cytoplasmic antibody with comorbidities and outcome in a hospital-based population. Heliyon 2024; 10(1): e24105 doi: 10.1016/j.heliyon.2024.e24105
|
17 |
D. A. Kuznetsova, S. V. Lapin, O. B. Shchukina, I. V. Gubonina, A. A. Kamanin. Predictive value of ASCA and ANCA in inflammatory bowel diseases. The Scientific Notes of the Pavlov University 2024; 31(1): 37 doi: 10.24884/1607-4181-2024-31-1-37-46
|
18 |
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson, Bruce E Sands. ACG Clinical Guideline: Management of Crohn's Disease in Adults. American Journal of Gastroenterology 2018; 113(4): 481 doi: 10.1038/ajg.2018.27
|
19 |
Tetsuhiro Yoshimura, Keiichi Mitsuyama, Ryosuke Sakemi, Hidetoshi Takedatsu, Shinichiro Yoshioka, Kotaro Kuwaki, Atsushi Mori, Shuhei Fukunaga, Toshihiro Araki, Masaru Morita, Kozo Tsuruta, Hiroshi Yamasaki, Takuji Torimura, Tânia Silvia Fröde. Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease. Mediators of Inflammation 2021; 2021: 1 doi: 10.1155/2021/8825374
|
20 |
Xianzong Ma, Wenyu Zhang, Xin Wang, Lang Yang, Juan Jiao, Yan Jia, Dezhi Wang, Junfeng Xu, Peng Jin, Mingjie Zhang, Shirong Li, Yuanming Pan, Jianqiu Sheng. Clinical validation of serum immunosignatures in early diagnosis of Crohn's disease. iLABMED 2023; 1(3): 181 doi: 10.1002/ila2.28
|
21 |
Peter Hettegger, Jasmin Huber, Katharina Paßecker, Regina Soldo, Ulrike Kegler, Christa Nöhammer, Andreas Weinhäusel, Tommaso Lomonaco. High similarity of IgG antibody profiles in blood and saliva opens opportunities for saliva based serology. PLOS ONE 2019; 14(6): e0218456 doi: 10.1371/journal.pone.0218456
|
22 |
Kendra A. Klag, June L. Round. Microbiota-Immune Interactions Regulate Metabolic Disease. The Journal of Immunology 2021; 207(7): 1719 doi: 10.4049/jimmunol.2100419
|
23 |
Anna L. Rundle, Nicole Baron, Rita Marie John. Pediatric Diagnostic Labs for Primary Care: An Evidence-based Approach. 2022; : 319 doi: 10.1007/978-3-030-90642-9_9
|
24 |
Lizhi Zhang, Tsung-Teh Wu. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases. 2019; : 373 doi: 10.1007/978-3-030-15573-5_15
|
25 |
Irene Marafini, Federica Laudisi, Silvia Salvatori, Diletta Lavigna, Chiara Venuto, Diana Giannarelli, Giovanni Monteleone. Diagnostic value of anti-integrin αvβ6 antibodies in ulcerative colitis. Digestive and Liver Disease 2024; 56(1): 55 doi: 10.1016/j.dld.2023.06.024
|
26 |
Kamila Majidova, Julia Handfield, Kamran Kafi, Ryan D. Martin, Ryszard Kubinski. Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review. Genes 2021; 12(10): 1465 doi: 10.3390/genes12101465
|
27 |
Amelie Bos, Marjolein van Egmond, Reina Mebius. The role of retinoic acid in the production of immunoglobulin A. Mucosal Immunology 2022; 15(4): 562 doi: 10.1038/s41385-022-00509-8
|
28 |
Laura Räisänen, Heli Viljakainen, Kaija-Leena Kolho. Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases. Frontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1157547
|
29 |
D. А. Kuznetsova, S. V. Lapin, O. B. Shchukina. The diagnostic and prognostic value of serological markers of inflammatory bowel diseases (a literature review). Almanac of Clinical Medicine 2020; 48(6): 364 doi: 10.18786/2072-0505-2020-48-061
|
30 |
Kristina Martinez-Guryn, Vanessa Leone, Eugene B. Chang. Regional Diversity of the Gastrointestinal Microbiome. Cell Host & Microbe 2019; 26(3): 314 doi: 10.1016/j.chom.2019.08.011
|
31 |
Ayman S Bannaga, Alexia Farrugia, Ramesh P Arasaradnam. Diagnosing Inflammatory bowel disease using noninvasive applications of volatile organic compounds: a systematic review. Expert Review of Gastroenterology & Hepatology 2019; 13(11): 1113 doi: 10.1080/17474124.2019.1685873
|
32 |
Yanzhuo Su, Haomin Zhao. Predisposition of Inflammatory Bowel Disease Is Influenced by <b><i>IL-8</i></b>, <b><i>IL-10</i></b>, and <b><i>IL-18</i></b> Polymorphisms: A Meta-Analysis. International Archives of Allergy and Immunology 2020; 181(10): 799 doi: 10.1159/000509110
|
33 |
Peng Chen, Gaoshi Zhou, Jingxia Lin, Li Li, Zhirong Zeng, Minhu Chen, Shenghong Zhang. Serum Biomarkers for Inflammatory Bowel Disease. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00123
|
34 |
Vincenzo Villanacci, Luca Reggiani-Bonetti, Tiziana Salviato, Giuseppe Leoncini, Moris Cadei, Luca Albarello, Alessandro Caputo, Maria Costanza Aquilano, Serena Battista, Paola Parente. Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD). Pathologica 2021; 113(1): 39 doi: 10.32074/1591-951X-235
|
35 |
A. V. Nikitin, G. V. Volynets. Sclerosing cholangitis and inflammatory bowel disease: which comes first?. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66(1): 39 doi: 10.21508/1027-4065-2021-66-1-39-46
|
36 |
Melanie Schirmer, Ashley Garner, Hera Vlamakis, Ramnik J. Xavier. Microbial genes and pathways in inflammatory bowel disease. Nature Reviews Microbiology 2019; 17(8): 497 doi: 10.1038/s41579-019-0213-6
|
37 |
E. N. Aleksandrova, A. A. Novikov, G. V. Lukina, A. I. Parfenov. Clinical value of antibodies in inflammatory bowel diseases. Terapevticheskii arkhiv 2021; 93(2): 228 doi: 10.26442/00403660.2021.02.200610
|
38 |
Tatsuki Mizuochi, Katsuhiro Arai, Takahiro Kudo, Ryusuke Nambu, Hitoshi Tajiri, Tomoki Aomatsu, Naoki Abe, Toshihiko Kakiuchi, Kunio Hashimoto, Tsuyoshi Sogo, Michiko Takahashi, Yuri Etani, Yugo Takaki, Ken-ichiro Konishi, Jun Ishihara, Hitoshi Obara, Tatsuyuki Kakuma, Shunsuke Kurei, Yushiro Yamashita, Keiichi Mitsuyama. Antibodies to Crohn’s disease peptide 353 as a diagnostic marker for pediatric Crohn’s disease: a prospective multicenter study in Japan. Journal of Gastroenterology 2020; 55(5): 515 doi: 10.1007/s00535-019-01661-y
|
39 |
Leidi Hernandez-Suarez, Eguzkiñe Diez-Martin, June Egiguren-Ortiz, Roberto Fernandez, Aitor Etxebarria, Egoitz Astigarraga, Cristina Miguelez, Andoni Ramirez-Garcia, Gabriel Barreda-Gómez. Serological Antibodies against Kidney, Liver, and Spleen Membrane Antigens as Potential Biomarkers in Patients with Immune Disorders. International Journal of Molecular Sciences 2024; 25(4): 2025 doi: 10.3390/ijms25042025
|
40 |
Carlos Arturo Rojas Rodríguez, Santiago Sánchez Londoño, Nelson Rojas, Mauricio Sepúlveda Copete, Jairo Alberto García Abadía, Diego Fernando Jiménez Rivera, Catalina Maldonado Gutiérrez, Angélica Tobón Guevara. Descripción clínico-epidemiológica de pacientes con enfermedad inflamatoria intestinal en una clínica de cuarto nivel en Cali. Revista Colombiana de Gastroenterología 2020; 35(2): 166 doi: 10.22516/25007440.409
|
41 |
Pablo Alagón Fernández del Campo, Alejandro De Orta Pando, Juan Ignacio Straface, José Ricardo López Vega, Diego Toledo Plata, Sebastian Felipe Niezen Lugo, Diego Alvarez Hernández, Tomás Barrientos Fortes, Laila Gutiérrez-Kobeh, Sandra Georgina Solano-Gálvez, Rosalino Vázquez-López. The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases. Medical Sciences 2019; 7(2): 33 doi: 10.3390/medsci7020033
|
42 |
Maria M. Xu, Patrick A. Murphy, Anthony T. Vella. Activated T-effector seeds: cultivating atherosclerotic plaque through alternative activation. American Journal of Physiology-Heart and Circulatory Physiology 2019; 316(6): H1354 doi: 10.1152/ajpheart.00148.2019
|
43 |
Sihem Ait‐Oudhia, Yi Ting (Kayla) Lien, Sumit Basu, Lawrence Lesko, Stephan Schmidt. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases. 2019; : 209 doi: 10.1002/9781119289234.ch10
|
44 |
Hu Zhang, Zhen Zeng, Arjudeb Mukherjee, Bo Shen. Molecular diagnosis and classification of inflammatory bowel disease. Expert Review of Molecular Diagnostics 2018; 18(10): 867 doi: 10.1080/14737159.2018.1516549
|
45 |
Eric Gracey, Lars Vereecke, Dermot McGovern, Mareike Fröhling, Georg Schett, Silvio Danese, Martine De Vos, Filip Van den Bosch, Dirk Elewaut. Revisiting the gut–joint axis: links between gut inflammation and spondyloarthritis. Nature Reviews Rheumatology 2020; 16(8): 415 doi: 10.1038/s41584-020-0454-9
|
46 |
Wenjie Liu, Chunhui Wang, Lijuan Tang, Hui Yang. Associations between Gene Polymorphisms in Pro-inflammatory Cytokines and the Risk of Inflammatory Bowel Disease: A Meta-analysis. Immunological Investigations 2021; 50(8): 869 doi: 10.1080/08820139.2020.1787438
|
47 |
Laura K. Räisänen, Sohvi E. Kääriäinen, Reijo Sund, Elina Engberg, Heli T. Viljakainen, Kaija-Leena Kolho. Antibiotic exposures and the development of pediatric autoimmune diseases: a register-based case–control study. Pediatric Research 2023; 93(4): 1096 doi: 10.1038/s41390-022-02188-4
|
48 |
Mahmoud Khatib A.A. Al-Ruweidi, Nada Khater, Haya Rashid Alkaabi, Maram Hasan, Huseyin C. Yalcin. Immunology of the GI Tract - Recent Advances. 2022; doi: 10.5772/intechopen.106184
|
49 |
Elizabeth A Spencer, Sonia M Davis, David R Mack, Brendan M Boyle, Anne M Griffiths, Neal S LeLeiko, Cary G Sauer, David J Keljo, James F Markowitz, Susan S Baker, Joel R Rosh, Robert N Baldassano, Maria Oliva-Hemker, Marian D Pfefferkorn, Anthony R Otley, Melvin B Heyman, Joshua D Noe, Ashish S Patel, Paul A Rufo, Keith Benkov, Jonathan Evans, Stephen Guthery, Michael Kappelman, Dedrick Moulton, Jennifer Strople, Boris Sudel, Prateek Wali, David Ziring, Vin Tangpricha, M Alison Marquis, Thomas D Walters, Margaret H Collins, Subra Kugathasan, Lee A Denson, Jeffrey S Hyams, Marla C Dubinsky. Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children. Inflammatory Bowel Diseases 2018; 24(6): 1335 doi: 10.1093/ibd/izy009
|
50 |
Eula Plana Tetangco, Adam C. Stein. Medical treatment of intestinal Crohn's disease. Seminars in Colon and Rectal Surgery 2022; 33(1): 100862 doi: 10.1016/j.scrs.2022.100862
|
51 |
Annelot Breedveld, Marjolein van Egmond. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00553
|
52 |
Marcel Vetter, M. F. Neurath, Raja Atreya. Biomarker verbessern Versorgung des M. Crohn. MMW - Fortschritte der Medizin 2017; 159(3): 63 doi: 10.1007/s15006-017-9279-0
|
53 |
Seung Min Hong, Dong Hoon Baek. Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond. Diagnostics 2024; 14(13): 1384 doi: 10.3390/diagnostics14131384
|
54 |
Xue Bai, Sijie Chen, Xinxin Chi, Bowen Xie, Xinyi Guo, Han Feng, Peng Wei, Di Zhang, Shan Xie, Tian Xie, Yongzhen Chen, Mengting Gou, Qin Qiao, Xinwei Liu, Wei Jin, Wei Xu, Zixuan Zhao, Qi Xing, Xiaohu Wang, Xuegong Zhang, Chen Dong. Reciprocal regulation of T follicular helper cells and dendritic cells drives colitis development. Nature Immunology 2024; 25(8): 1383 doi: 10.1038/s41590-024-01882-1
|
55 |
Eguzkiñe Diez-Martin, Leidi Hernandez-Suarez, Carmen Muñoz-Villafranca, Leire Martin-Souto, Egoitz Astigarraga, Andoni Ramirez-Garcia, Gabriel Barreda-Gómez. Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options. International Journal of Molecular Sciences 2024; 25(13): 7062 doi: 10.3390/ijms25137062
|
56 |
Karin Fetter, Markus Weigel, Benjamin Ott, Moritz Fritzenwanker, Sebastian Stricker, Jan de Laffolie, Torsten Hain. The microbiome landscape in pediatric Crohn’s disease and therapeutic implications. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2247019
|
57 |
Katharina Kappler, Yi Lasanajak, David F. Smith, Lennart Opitz, Thierry Hennet. Increased Antibody Response to Fucosylated Oligosaccharides and Fucose-Carrying Bacteroides Species in Crohn’s Disease. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.01553
|
58 |
Kashika Arora, Giulia Gaudioso, Pavel Solovyev, Kieran Tuohy, Raffaella Di Cagno, Marco Gobbetti, Francesca Fava. In vitro faecal fermentation of Tritordeum breads and its effect on the human gut health. Current Research in Microbial Sciences 2024; 6: 100214 doi: 10.1016/j.crmicr.2023.100214
|
59 |
Arno R. Bourgonje, Sergio Andreu-Sánchez, Thomas Vogl, Shixian Hu, Arnau Vich Vila, Ranko Gacesa, Sigal Leviatan, Alexander Kurilshikov, Shelley Klompus, Iris N. Kalka, Hendrik M. van Dullemen, Adina Weinberger, Marijn C. Visschedijk, Eleonora A.M. Festen, Klaas Nico Faber, Cisca Wijmenga, Gerard Dijkstra, Eran Segal, Jingyuan Fu, Alexandra Zhernakova, Rinse K. Weersma. Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signatures. Immunity 2023; 56(6): 1393 doi: 10.1016/j.immuni.2023.04.017
|
60 |
David M. Underhill, Jonathan Braun. Fungal microbiome in inflammatory bowel disease: a critical assessment. Journal of Clinical Investigation 2022; 132(5) doi: 10.1172/JCI155786
|
61 |
Arno R. Bourgonje, Thomas Vogl, Eran Segal, Rinse K. Weersma. Antibody signatures in inflammatory bowel disease: current developments and future applications. Trends in Molecular Medicine 2022; 28(8): 693 doi: 10.1016/j.molmed.2022.05.004
|
62 |
O. Yu. Tkachenko, S. V. Lapin, A. V. Masing, T. V. Blinova, A. N. Moshnikova, D. A. Kuznetsova, I. V. Kholopova. Diagnostic value of autoantibodies and novel automated methods of their detection. Medical alphabet 2022; 1(6): 40 doi: 10.33667/2078-5631-2022-6-40-46
|
63 |
Jin Yan, Feihong Deng, Yuyong Tan, Bingyi Zhou, Deliang Liu. Systemic immune-inflammation index as a potential biomarker to monitor ulcerative colitis. Current Medical Research and Opinion 2023; 39(10): 1321 doi: 10.1080/03007995.2023.2257599
|
64 |
Yue Yin, Yusen Hu, Yanning Li, Xia Peng, Huanjin Liao, Wei Shen, Li Li. Prevalence and Clinical Relevance of Anti-FcεRI Autoantibody in Crohn’s Disease. Journal of Asthma and Allergy 2024; : 833 doi: 10.2147/JAA.S476501
|
65 |
Tsvetelina Veselinova Velikova, Zoya Angelova Spassova, Lyuben Mitkov Milatchkov, Dobriana Georgieva Panova, Ekaterina Ivanova Ivanova - Todorova, Kalina Dinkova Tumangelova - Yuzeir, Ekaterina Krasimirova Kurteva, Dobroslav Stanimirov Kyurkchiev, Siragan Arshavir Deredjan, Rosen Kirilov Nikolov, Iskra Petrova Altankova, Lyudmila Mateva Vladimirova. Dynamics of Some Routine Immunological Parameters During Anti - TNF Therapy in Patients with Crohn’s Disease. Annals of Colorectal Research 2018; 6(1) doi: 10.5812/acr.68674
|
66 |
Serena Longo, Marcello Chieppa, Luca G. Cossa, Chiara C. Spinelli, Marco Greco, Michele Maffia, Anna M. Giudetti. New Insights into Inflammatory Bowel Diseases from Proteomic and Lipidomic Studies. Proteomes 2020; 8(3): 18 doi: 10.3390/proteomes8030018
|
67 |
Toshiyuki Sakurai, Masayuki Saruta. Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease. Digestion 2023; 104(1): 30 doi: 10.1159/000527846
|
68 |
Weifeng Wang, Lixia Wu, Xuan Wu, Ke Li, Tianming Li, Bei Xu, Weiwei Liu. Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC. Clinica Chimica Acta 2021; 514: 8 doi: 10.1016/j.cca.2020.12.014
|
69 |
Riccardo Mager, Giulia Roda, Mohammad Khaled Shalaby, Stefania Vetrano. Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors. Current Drug Targets 2021; 22(2): 241 doi: 10.2174/1389450121666201020160803
|
70 |
Emmanuel U Emeasoba, Cece E Ibeson, Sanchit Kundal, Stefanie Biondi, Ifeanyi Nwosu, Shmuel Golfeyz, Michael Kantrowitz, Dimitry Khodorskiy. A Rare Case of New-Onset Ulcerative Colitis in a Nonagenarian. Cureus 2022; doi: 10.7759/cureus.26203
|
71 |
Dan Vălean, Roxana Zaharie, Roman Țaulean, Lia Usatiuc, Florin Zaharie. Recent Trends in Non-Invasive Methods of Diagnosis and Evaluation of Inflammatory Bowel Disease: A Short Review. International Journal of Molecular Sciences 2024; 25(4): 2077 doi: 10.3390/ijms25042077
|
72 |
Harshi Weerakoon, Ailin Lepletier. Regulatory T Cells and Autoimmune Diseases. 2024; : 351 doi: 10.1016/B978-0-443-13947-5.00015-4
|
73 |
Duk Hwan Kim, Jae Hee Cheon. Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Network 2017; 17(1): 25 doi: 10.4110/in.2017.17.1.25
|
74 |
Melissa Maria Johanna van Gool, Marjolein van Egmond. IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity. ImmunoTargets and Therapy 2021; : 351 doi: 10.2147/ITT.S266242
|
75 |
Arup Choudhury, Jasdeep Dhillon, Aravind Sekar, Pankaj Gupta, Harjeet Singh, Vishal Sharma. Differentiating gastrointestinal tuberculosis and Crohn's disease- a comprehensive review. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02887-0
|
76 |
John W. Frew, David Grand, Kristina Navrazhina, James G. Krueger. Beyond antibodies: B cells in Hidradenitis Suppurativa: Bystanders, contributors or therapeutic targets?. Experimental Dermatology 2020; 29(5): 509 doi: 10.1111/exd.14092
|
77 |
Michal Pyzik, Lisa K. Kozicky, Amit K. Gandhi, Richard S. Blumberg. The therapeutic age of the neonatal Fc receptor. Nature Reviews Immunology 2023; 23(7): 415 doi: 10.1038/s41577-022-00821-1
|
78 |
Steven J Edwards, Samantha Barton, Mariana Bacelar, Charlotta Karner, Peter Cain, Victoria Wakefield, Gemma Marceniuk. Prognostic tools for identification of high risk in people with Crohn’s disease: systematic review and cost-effectiveness study. Health Technology Assessment 2021; 25(23): 1 doi: 10.3310/hta25230
|
79 |
Antonio Mestrovic, Nikola Perkovic, Dorotea Bozic, Marko Kumric, Marino Vilovic, Josko Bozic. Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers. Biomedicines 2024; 12(7): 1520 doi: 10.3390/biomedicines12071520
|
80 |
E. Ann Holmes, Rachael M. Rodney Harris, Robyn M. Lucas. Low Sun Exposure and Vitamin D Deficiency as Risk Factors for Inflammatory Bowel Disease, With a Focus on Childhood Onset. Photochemistry and Photobiology 2019; 95(1): 105 doi: 10.1111/php.13007
|
81 |
|
82 |
Shaoxuan Wang, Tingting Fan, Li Yao, Ran Ma, Shaofeng Yang, Fang Yuan. Circulating follicular regulatory T cells could inhibit Ig production in a CTLA-4-dependent manner but are dysregulated in ulcerative colitis. Molecular Immunology 2019; 114: 323 doi: 10.1016/j.molimm.2019.08.006
|
83 |
Jiawei Liu, Xiangwei Liu, Yingying Liu, Quan Bai. Pseudo-mercaptoethyl pyridine functionalized polyhedral oligomeric silsesquioxane-graphene composite via thiol-ene click reaction for highly selective purification of antibody. Journal of Chromatography B 2022; 1208: 123408 doi: 10.1016/j.jchromb.2022.123408
|
84 |
Piyapat Rintarhat, Yong-Joon Cho, Hong Koh, Sowon Park, Eun Joo Lee, Hyeji Lim, Jihye Noh, Dong-Woo Lee, Won Hee Jung. Assessment of DNA extraction methods for human gut mycobiome analysis. Royal Society Open Science 2024; 11(1) doi: 10.1098/rsos.231129
|
85 |
Aelita A. Kamalova, Marina A. Khanafina, Galina A. Garina. Clinical and Diagnostic Value of Inflammatory Bowel Diseases' Serological Markers in Children (Literature Review). Pediatric pharmacology 2023; 20(4): 309 doi: 10.15690/pf.v20i4.2605
|
86 |
Maram Alenzi, Tamar Schildkraut, Imogen Hartley, Sarit Badiani, Nik Sheng Ding, Vikram Rao, Jonathan P. Segal. The aetiology of pouchitis in patients with inflammatory bowel disease. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241249449
|
87 |
Louis J. Cohen, Judy H. Cho, Dirk Gevers, Hiutung Chu. Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases. Gastroenterology 2019; 156(8): 2174 doi: 10.1053/j.gastro.2019.03.017
|
88 |
Chiara Pellicano, Giorgia Leodori, Giuseppe Pietro Innocenti, Antonietta Gigante, Edoardo Rosato. Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes?. Nutrients 2019; 11(11): 2629 doi: 10.3390/nu11112629
|
89 |
Amosy E. M’Koma. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. Gastrointestinal Disorders 2018; 1(1): 75 doi: 10.3390/gidisord1010007
|
90 |
Bence Kővári, Ágnes Báthori, Mark S. Friedman, Gregory Y. Lauwers. Histologic Diagnosis of Inflammatory Bowel Diseases. Advances in Anatomic Pathology 2022; 29(1): 48 doi: 10.1097/PAP.0000000000000325
|
91 |
Anuraag Jena, Usha Dutta, Jimil Shah, Vishal Sharma, Kaushal K. Prasad, Rudramurthy M. Shivaprakash, Harshal S. Mandavdhare, Jayanta Samanta, Pankaj Sharma, Priyanka Popli, Arun K. Sharma, Saroj K. Sinha, Arunaloke Chakrabarti, Rakesh Kochhar. Oral Fluconazole Therapy in Patients With Active Ulcerative Colitis Who Have Detectable Candida in the Stool. Journal of Clinical Gastroenterology 2022; 56(8): 705 doi: 10.1097/MCG.0000000000001609
|
92 |
Mahasish Shome, Lusheng Song, Stacy Williams, Yunro Chung, Vel Murugan, Jin G Park, William Faubion, Shabana F Pasha, Jonathan A Leighton, Joshua LaBaer, Ji Qiu. Serological profiling of Crohn’s disease and ulcerative colitis patients reveals anti-microbial antibody signatures. World Journal of Gastroenterology 2022; 28(30): 4089-4101 doi: 10.3748/wjg.v28.i30.4089
|
93 |
Maiss Reghefaoui, Tariladei S Peresuodei, Michell S Saavedra Palacios, Abhishek Gill, Chijioke Orji, Tiba Reghefaoui, Jihan Mostafa. The Role of Serological Markers in the Prediction of Disease Course and Response to Therapy in Inflammatory Bowel Disease. Cureus 2023; doi: 10.7759/cureus.48442
|
94 |
Tatsuki Mizuochi, Katsuhiro Arai, Takahiro Kudo, Ryusuke Nambu, Hitoshi Tajiri, Tomoki Aomatsu, Naoki Abe, Toshihiko Kakiuchi, Kunio Hashimoto, Tsuyoshi Sogo, Michiko Takahashi, Yuri Etani, Yugo Takaki, Ken‐ichiro Konishi, Jun Ishihara, Hitoshi Obara, Tatsuyuki Kakuma, Shunsuke Kurei, Yushiro Yamashita, Keiichi Mitsuyama. Diagnostic accuracy of serum proteinase 3 antineutrophil cytoplasmic antibodies in children with ulcerative colitis. Journal of Gastroenterology and Hepatology 2021; 36(6): 1538 doi: 10.1111/jgh.15296
|
95 |
Juan J. Estruch, Jacqueline Johnson, Sarah Ford, Sean Yoshimoto, Tracy Mills, Philip Bergman. Response to letter regarding “Utility of the combined use of 3 serologic markers in the diagnosis and monitoring of chronic enteropathies in dogs”. Journal of Veterinary Internal Medicine 2021; 35(6): 2570 doi: 10.1111/jvim.16304
|
96 |
Sruthi Vijaya Retnakumar, Sylviane Muller. Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases. Trends in Molecular Medicine 2019; 25(6): 516 doi: 10.1016/j.molmed.2019.03.002
|
97 |
Giulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, Marjorie Argollo, Remo Panaccione, Antonino Spinelli, Arthur Kaser, Laurent Peyrin-Biroulet, Silvio Danese. Crohn’s disease. Nature Reviews Disease Primers 2020; 6(1) doi: 10.1038/s41572-020-0156-2
|
98 |
Hui Ma, Caroline Murphy, Christine E. Loscher, Richard O’Kennedy. Autoantibodies - enemies, and/or potential allies?. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.953726
|
99 |
Gerard E. Kaiko, Feidi Chen, Chin-Wen Lai, I-Ling Chiang, Jacqueline Perrigoue, Aleksandar Stojmirović, Katherine Li, Brian D. Muegge, Umang Jain, Kelli L. VanDussen, Bridie J. Goggins, Simon Keely, Jessica Weaver, Paul S. Foster, Daniel A. Lawrence, Ta-Chiang Liu, Thaddeus S. Stappenbeck. PAI-1 augments mucosal damage in colitis. Science Translational Medicine 2019; 11(482) doi: 10.1126/scitranslmed.aat0852
|
100 |
Patrick Chambers. Candida and Long Covid: Mannan Not from Heaven. Qeios 2024; doi: 10.32388/JE31EO.5
|
101 |
Anton Bermont, Efrat Broide, Shay Matalon, Vered Richter, Tsilia Lazarovitch, Haggai Bar-Yoseph, Haim Shirin. <p>New-Onset of Crohn’s Disease Is Associated with Antistreptolysin O Positive Titers</p>. Clinical and Experimental Gastroenterology 2020; : 187 doi: 10.2147/CEG.S245770
|
102 |
Suzanne Samarani, Patrick Sagala, Prevost Jantchou, Guy Grimard, Christophe Faure, Colette Deslandres, Devendra K. Amre, Ali Ahmad. Phenotypic and Functional Changes in Peripheral Blood Natural Killer Cells in Crohn Disease Patients. Mediators of Inflammation 2020; 2020: 1 doi: 10.1155/2020/6401969
|
103 |
Anthony Buisson, Emilie Vazeille, Mathurin Fumery, Benjamin Pariente, Stéphane Nancey, Philippe Seksik, Laurent Peyrin‐Biroulet, Matthieu Allez, Nathalie Ballet, Jérôme Filippi, Clara Yzet, Maria Nachury, Gilles Boschetti, Elisabeth Billard, Anaëlle Dubois, Stéphanie Rodriguez, Caroline Chevarin, Marion Goutte, Gilles Bommelaer, Bruno Pereira, Xavier Hebuterne, Nicolas Barnich. Faster and less invasive tools to identify patients with ileal colonization by adherent‐invasive E. coli in Crohn's disease. United European Gastroenterology Journal 2021; 9(9): 1007 doi: 10.1002/ueg2.12161
|
104 |
Huijuan Wang, Shuhong Zhou, Jiahong Zhang, Shangwen Lei, Jing Zhou. Correlations between TLR polymorphisms and inflammatory bowel disease: a meta-analysis of 49 case-control studies. Immunologic Research 2019; 67(1): 142 doi: 10.1007/s12026-018-9061-0
|
105 |
Meng-Hui Zhang, Han Wang, Hong-Gang Wang, Xin Wen, Xiao-Zhong Yang. Effective immune-inflammation index for ulcerative colitis and activity assessments. World Journal of Clinical Cases 2021; 9(2): 334-343 doi: 10.12998/wjcc.v9.i2.334
|